Table 4.
MRSA cSSTI Susceptibility Profile
| Antibiotica | All |
|
|---|---|---|
| N tested | % sensitive | |
| Linezolid | 116 | 100 |
| Vancomycin | 135 | 97.0 |
| Tigecycline | 87 | 96.6 |
| Daptomycin | 62 | 91.9 |
| Quinupristin–dalfopristin | 18 | 66.7 |
| Rifampicin | 48 | 64.6 |
| Trimethoprim/Sulfamethoxazole (TMP-SMX) | 119 | 37.0 |
| Clindamycin | 122 | 36.1 |
| Minocycline | 22 | 27.3 |
| Doxycycline | 63 | 20.6 |
| Fusidic Acid | 28 | 17.9 |
| Ciprofloxacin | 121 | 11.6 |
| Trimethoprim | 44 | 6.8 |
| B-lactam antibiotic/penicillin | 102 | 5.9 |
a
Other antibiotics with <10 tests, N tested (% sensitive): amikacin, 2 (100%); polymyxin, 1 (100%); gentamicin, 6 (66.7%); oxacillin, 2 (50%).